Treatment of retroperitoneal fibrosis with tamoxifen: Case report and review of literature

Archivos Espanoles de Urologia

Volumn 53, Issue 2, 2000, Pages 184-190

  Puce, Roberto ^a,b   Porcaro, A B ^a   Curti, P ^a   Girelli, D ^a   Pantalena, M ^a   Malossini, G ^a   Tallarigo, C ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b OSPEDALE POLICLINICO   (Italy)

Author keywords

Idiopathic retroperitoneal fibrosis; Tamoxifen; Ureteral obstruction

Indexed keywords

TAMOXIFEN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; INTRAVENOUS PYELOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE UROPATHY; RETROPERITONEAL FIBROSIS; URETER STENT;

ACUTE DISEASE; AGED; ESTROGEN ANTAGONISTS; HUMANS; MALE; RETROPERITONEAL FIBROSIS; TAMOXIFEN;

EID: 0034086305     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. MENSI, M.; PEIRANO, P.; CEBRELLI, T. et al.: "Fibrosi retroperitoneale." Urologia, 63: 123, 1996.
2. AMIS, E.S.: "Retroperitoneal fibrosis." AJR, 157: 321, 1991.
3. ORMOND, J.K.: "Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process." J. Urol., 59: 1072, 1948.
4. MORAD, N.; STRONGWATER, S.; EYPPER, S. et al.: "Idiopathic retroperitoneal fibrosis mimicking connective tissue disease." Am. J. Med., 82: 363, 1987.
5. BEST, T.B.; MUNRO, R.E.; BURWELL, S. et al : "Riedel's thyroiditis associated with Hashimoto's thyroiditis, hypoparathyroidism and retroperitoneal fibrosis." J. Endocrinol. Invest., 14: 767, 1991.
6. ELEWAUT, D.; RUBENS, R.; ELEWAUT, A. et al.: "Lusoria dysphagia in a patient with retroperitoneal fibrosis and Riedel's thyroiditis." J. Int. Med., 239: 75, 1996.
7. SCHUMACHER, H.R.: "Multifocal fibrosclerosis." In: Wyngaarden, J.B. and Smith, L.H. (eds.): Cecil Textbookd of Medicine. W.B. Saunders, Philadelphia, 18th Ed., vol. 2, p. 2051, 1988.
8. STEWART, T.W. Jr.; FRIBERG, T.R.: "Idiopathic retroperitoneal fibrosis with diffuse involvement: further evidence of systemic idiopathic fibrosis." South Med. J., 77: 1185, 1984.
9. MITCHINSON, M.J.: "Aortic desease in idiopathic retroperitoneal and mediastinal fibrosis." J. Clin. Pathol., 25: 287, 1972.
10. MITCHINSON, M.J.: "The pathology of idiopathic retroperitoneal fibrosis." J. Clin. Pathol., 23: 681, 1970.
11. WHAL, S.M.: McCARTNEY-FRANCIS, N.; MARGENHAGEN, S.E.: "Inflammatory and immunomodulatory roles of TGF-β." Immunol. Today, 10: 258, 1989.
12. PARUMS, D.V.: "The spectrum of chronic periaortitis." Histopathology, 16: 423, 1990.
13. GRAHAM, J R.; SUBY, H.J.; LECOMPTE, P.R.: "Fibrotic disorders associated with methisergide therapy for headache." N. Engl. J. Med., 74: 359, 1966.
14. CID, M.C.: "New developments in the pathogenesis of systemic vasculitis." In: Hunder, G G. (ed): "Current Opinions in Rheumatology." Philadelphia, Rapid Science Publishers, vol. 8, pag. 1, 1996.
15. DENES, F.T.; ARAP, S.: "Retroperitoneal fibrosis: an alternative therapy." Eur. Urol., 12: 283, 1986.
16. VAN HERPE, H.; VON WALDTHAUSEN, W.; ROGGENBUCK, R. et al.: "The treatment of retropentoneal fibrosis Report of personal experience with 17 cases." Helv. Chir. Acta, 57: 455, 1990.
17. TIPTAFT, R.C.; COSTELLO, A.J.; PARIS, A.M.I. et al.: "The long-term follow-up of idiopathic retroperitoneal fibrosis." Br. J. Urol., 54: 620, 1982.
18. CHAN, S.L.; JOHNSON, H.W.; McLOUGHLIN, M.G : "Idiopathic retroperitoneal fibrosis in children." J. Urol., 122: 103, 1979.
19. McDOUGAL, W.S.; Mac DONNEL, R.C. Jr.: "Treatment of idiopathic retroperitoneal fibrosis by immunosupprension." J. Urol., 145: 112, 1991.
20. KOLHER, H.P.; LAENG, R.H.; EGGER, C. et al.: "Systemic fibrosis (generalized form of Ormond's disease). Report of a case which achieved complete remission with cyclophosphamide and corticosteroids." Schweiz Med. Wochenschr., 125: 2131, 1995.
21. SCAVALLI, A.S ; SPADARO, A.; RICCIERI, V. et al.: "Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis." Clin. Rheumatol., 14: 481, 1995.
22. CRONSTEIN, B.N.; NAIME, D.; OSTAD, E.: "The antiinflammatory mechanism of methotrexate." J. Clin. Invest., 92: 2675, 1993.
23. CRONSTEIN, B.N.; NAIME, D.; FIRESTEIN, G.: "The antiinflammaiory effects of an adenosine kinase inhibitor are mediated by adenosine " Arthritis Rheum., 38: 1040, 1995.
24. NEASE, R.F.; ROSS, J.M.: "The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healty women." A. J. Med., 99: 180, 1995.
25. LOFFELD, R.J.L.F.; VAN WEEL Th.F.: "Tamoxifen for retroperitoneal fibrosis." Lancet, 342: 328, 1993.
26. ALBERTI, C.: "The rationale of tamoxifen in the management of retropentoneal fibrosis and Peyronie's disease. A review." Acta Urol. Ital., 10: 7, 1996.
27. CLARK, C P.; VANDERPOOL, D ; PRESKITT, J.T.: "The response of retroperitoneal fibrosis of tamoxifen." Surgery, 109: 502, 1991.
28. SPILLANE, R.M.; WHITMAN, G.J.: "Treatment of retroperitoneal fibrosis with tamoxifen." AJR, 164: 515, 1995.
29. COLLETTA, A.A.; WAKEFIELD, L.M.; HOWELL, F.V. et al.: "Anti-oestrogens induce the secretion of active transforming growth factor-beta from human fetal fibroblasts." Br. J. Cancer, 62: 405, 1990.
30. BENSON, J.R.; BAUM, M.: "Tamoxifen for retroperitoneal fibrosis." Lancet, 341: 836, 1993.
31. KOGA, M.; SUTHERLAND, R.L.: "Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growth." Bioch. Biophys. Res. Commun., 146: 739, 1987.